Combined Diffusion Imaging and MR Spectroscopy in the Diagnosis of Human Prion Diseases

References

1. 1.↵
   1. Bahn MM,
   2. Parchi P

   . Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol 1999;56:577–83

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Finkenstaedt M,
   2. Szudra A,
   3. Zerr I,
   4. et al

   . MR imaging of Creutzfeldt-Jakob disease. Radiology 1996;199:793–98

   PubMedWeb of Science
3. 3.↵
   1. Haik S,
   2. Dormont D,
   3. Faucheux BA,
   4. et al

   . Prion protein deposits match magnetic resonance imaging signal abnormalities in Creutzfeldt-Jakob disease. Ann Neurol 2002;51:797–99

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Oppenheim C,
   2. Zuber M,
   3. Galanaud D,
   4. et al

   . Spectroscopy and serial diffusion MR findings in hGH-Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2004;75:1066–69

   Abstract/FREE Full Text
5. 5.↵
   1. Tribl GG,
   2. Strasser G,
   3. Zeitlhofer J,
   4. et al

   . Sequential MRI in a case of Creutzfeldt-Jakob disease. Neuroradiology 2002;44:223–26

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Ukisu R,
   2. Kushihashi T,
   3. Kitanosono T,
   4. et al

   . Serial diffusion-weighted MRI of Creutzfeldt-Jakob disease. AJR Am J Roentgenol 2005;184:560–66

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Brandel JP,
   2. Delasnerie-Laupretre N,
   3. Laplanche JL,
   4. et al.

   , Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology 2000;54:1095–99

   Abstract/FREE Full Text
8. 8.↵
   1. Haik S,
   2. Galanaud D,
   3. Linguraru MG,
   4. et al

   . In vivo detection of thalamic gliosis: a pathoradiologic demonstration in familial fatal insomnia. Arch Neurol 2008;65:545–49

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Nicoli F,
   2. Lefur Y,
   3. Denis B,
   4. et al

   . Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke: a brain proton magnetic resonance spectroscopic imaging study. Stroke 2003;34:e82–87

   CrossRef
10. 10.↵
    1. Galanaud D,
    2. Dormont D,
    3. Grabli D,
    4. et al

    . MR spectroscopic pulvinar sign in a case of variant Creutzfeldt-Jakob disease. J Neuroradiol 2002;29:285–87

    PubMed
11. 11.↵
    1. Galanaud D,
    2. Le Fur Y,
    3. Nicoli F,
    4. et al

    . Regional metabolite levels of the normal posterior fossa studied by proton chemical shift imaging. MAGMA 2001;13:127–33

    CrossRefPubMed
12. 12.↵
    1. Frahm J,
    2. Bruhn H,
    3. Gyngell M,
    4. et al

    . Localized proton spectroscopy using stimulated echoes: initial application to human brain in vivo. Magn Reson Med 1989;9:79–93

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Michaelis T,
    2. Merboldt K,
    3. Hänicke W,
    4. et al

    . On the identification of cerebral metabolites in localized H-1 NMR spectra of the human brain in vivo. NMR Biomed 1991;4:90–98

    PubMedWeb of Science
14. 14.↵
    1. Confort-Gouny S,
    2. Vion-Dury J,
    3. Nicoli F,
    4. et al

    . A multiparametric data analysis showing the potential of localized proton MR spectroscopy in the brain in the metabolic characterization of neurological diseases. J Neurol Sci 1993;118:123–33

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Galanaud D,
    2. Nicoli F,
    3. Chinot O,
    4. et al

    . Noninvasive diagnostic assessment of brain tumors using combined in vivo MR imaging and spectroscopy. Magn Reson Med 2006;55:1236–45

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Chang L,
    2. Ernst T,
    3. Osborn D,
    4. et al

    . Proton spectroscopy in myotonic dystrophy. Arch Neurol 1998;55:305–11

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Fernando KT,
    2. McLean MA,
    3. Chard DT,
    4. et al

    . Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2004;127:1361–69

    Abstract/FREE Full Text
18. 18.↵
    1. Vrenken H,
    2. Barkhof F,
    3. Uitdehaag BM,
    4. et al

    . MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magn Reson Med 2005;53:256–66

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Matoba M,
    2. Tonami H,
    3. Miyaji H,
    4. et al

    . Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI. J Comput Assist Tomogr 2001;25:274–77

    CrossRefPubMed
20. 20.↵
    1. Krasnianski A,
    2. Kallenberg K,
    3. Collie DA,
    4. et al

    . MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement study. Eur J Neurol 2008;15:762–71

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Pandya HG,
    2. Coley SC,
    3. Wilkinson ID,
    4. et al

    . Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt-Jakob disease. Clin Radiol 2003;58:148–53

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Graham GD,
    2. Petroff OA,
    3. Blamire AM,
    4. et al

    . Proton magnetic resonance spectroscopy in Creutzfeldt-Jakob disease. Neurology 1993;43:2065–68

    Abstract/FREE Full Text
23. 23.↵
    1. Behar KL,
    2. Boucher R,
    3. Fritch W,
    4. et al

    . Changes in N-acetylaspartate and myo-inositol detected in the cerebral cortex of hamsters with Creutzfeldt-Jakob disease. Magn Reson Imaging 1998;16:963–68

    CrossRefPubMed
24. 24.↵
    1. Konaka K,
    2. Kaido M,
    3. Okuda Y,
    4. et al

    . Proton magnetic resonance spectroscopy of a patient with Gerstmann-Straussler-Scheinker disease. Neuroradiology 2000;42:662–65

    CrossRefPubMed
25. 25.↵
    1. Lim CC,
    2. Tan K,
    3. Verma KK,
    4. et al

    . Combined diffusion-weighted and spectroscopic MR imaging in Creutzfeldt-Jakob disease. Magn Reson Imaging 2004;22:625–29

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Cordery RJ,
    2. Macmanus D,
    3. Godbolt A,
    4. et al

    . Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease. Eur Radiol 2006;16:1–7. Epub 2006 Jan 12

    CrossRefPubMed
27. 27.↵
    1. Broom KA,
    2. Anthony DC,
    3. Lowe JP,
    4. et al

    . MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes. Neurobiol Dis 2007;26:707–17. Epub 2007 Apr 5

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Mittal S,
    2. Farmer P,
    3. Kalina P,
    4. et al

    . Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. Arch Neurol 2002;59:128–34

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Parchi P,
    2. Giese A,
    3. Capellari S,
    4. et al

    . Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224–33

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Brandel JP,
    2. Heath CA,
    3. Head MW,
    4. et al

    . Variant Creutzfeldt-Jakob disease in France and the United Kingdom: evidence for the same agent strain. Ann Neurol 2009;65:249–56

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Billette de Villemeur T,
    2. Gelot A,
    3. Deslys JP,
    4. et al

    . Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study. Neuropathol Appl Neurobiol 1994;20:111–17

    PubMedWeb of Science
32. 32.↵
    1. Tschampa HJ,
    2. Kallenberg K,
    3. Urbach H,
    4. et al

    . MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain 2005;128(pt 9):2026–33. Epub 2005 Jun 15

    Abstract/FREE Full Text
33. 33.↵
    1. Young GS,
    2. Geschwind MD,
    3. Fischbein NJ,
    4. et al

    . Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005;26:1551–62

    Abstract/FREE Full Text
34. 34.↵
    1. Shiga Y,
    2. Miyazawa K,
    3. Sato S,
    4. et al

    . Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004;63:443–49

    Abstract/FREE Full Text
35. 35.↵
    1. Meissner B,
    2. Kallenberg K,
    3. Sanchez-Juan P,
    4. et al

    . Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2008;29:1519–24

    Abstract/FREE Full Text
36. 36.↵
    1. Fulbright RK,
    2. Hoffmann C,
    3. Lee H,
    4. et al

    . MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol 2008;29:1638–43

    Abstract/FREE Full Text